Martin Steegmaier, Reutlingen DE
Martin Steegmaier, Reutlingen DE
Patent application number | Description | Published |
---|---|---|
20090149438 | Pyrimidines as PLK inhibitors - The present invention encompasses compounds of general formula (1), | 06-11-2009 |
20090163465 | Pyrimidines as PLK inhibitors - The present invention encompasses compounds of general formula (1), | 06-25-2009 |
20090238828 | Combinations for the Treatment of Diseases involving Cell Proliferation - Disclosed are pharmaceutical compositions for the treatment of diseases which involve cell proliferation. Also disclosed are methods for the treatment of said diseases, comprising co-administration of a compound 1 of Formula (I) | 09-24-2009 |
20090306067 | 2, 4-DIAMINOPYRIMIDIDE DERIVATES AND THEIR USE FOR THE TREATMENT OF CANCER - The present invention encompasses compounds of general formula (1) wherein Q and R | 12-10-2009 |
20100029642 | Methods of Using Pyridodihydropyrazinones - Disclosed are pyridodihydropyrazinone compounds, processes for preparing them and their use as pharmaceutical compositions. The compounds according to the invention correspond to general formula (I), | 02-04-2010 |
20100113414 | THIAZOLYL-DIHYDRO-INDAZOLES - The present invention encompasses compounds of the general formula (1) | 05-06-2010 |
20100152167 | PYRIMIDINE DERIVATIVES - The present invention relates to trisubstituted pyrimidines of formula (I) | 06-17-2010 |
20100240657 | CHEMICAL COMPOUNDS - The present invention encompasses compounds of general formula (1) wherein the groups R | 09-23-2010 |
20100324288 | Dihydropteridinone Compounds - Disclosed are new dihydropteridinones of general formula (I) | 12-23-2010 |
20110059938 | NEW CHEMICAL COMPOUNDS - The present invention encompasses compounds of general formula (1) | 03-10-2011 |
20110086842 | Pyrimidines as PLK inhibitors - The present invention encompasses compounds of general formula (1), | 04-14-2011 |
20120107312 | Combinations for the Treatment of Diseases involving Cell Proliferation - Disclosed are pharmaceutical compositions for the treatment of diseases which involve cell proliferation. Also disclosed are methods for the treatment of said diseases, comprising co-administration of a compound 1 of Formula (I) | 05-03-2012 |